Baeuerle, Patrick

Affiliated Entities

Cancervax Corp	Cullinan Oncology, LLC	Harpoon Therapeutics, Inc.	Tcr2 Therapeutics, Inc.

On PlainSite Chat

No one has posted about Baeuerle, Patrick yet.

Share something about Baeuerle, Patrick:

An active PlainSite Pro or Pro Se subscription is required to view the Activity Timeline.

Outside Counsel (1)

	Last Name	First Name	Middle Name	Firm	Location
	Chapman	Ernest		Finnegan, Henderson, Farabow, Garrett & Dunn...	Washington, DC

Insider Trading History

SEC Filings

Filter By Form All Records 3 4 5 From To

	Date	Entity	Form Number	Description	Value
	2/21/2023	Cullinan Oncology, LLC	4	Statement of changes in beneficial ownership of securities
	2/15/2022	Cullinan Oncology, LLC	4	Statement of changes in beneficial ownership of securities
	9/9/2021	Cullinan Oncology, LLC	4	Statement of changes in beneficial ownership of securities	$360.3K
	8/26/2021	Cullinan Oncology, LLC	4	Statement of changes in beneficial ownership of securities	$344.3K
	1/11/2021	Cullinan Oncology, LLC	4	Statement of changes in beneficial ownership of securities
	1/7/2021	Cullinan Oncology, LLC	3	Initial statement of beneficial ownership of securities
	12/11/2020	Tcr2 Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	6/1/2020	Harpoon Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	12/30/2019	Harpoon Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities	$1.40M
	12/26/2019	Tcr2 Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities	$1.80M
	6/5/2019	Harpoon Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	4/12/2019	Tcr2 Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	3/29/2019	Harpoon Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	2/13/2019	Tcr2 Therapeutics, Inc.	3	Initial statement of beneficial ownership of securities
	2/7/2019	Harpoon Therapeutics, Inc.	3	Initial statement of beneficial ownership of securities
	3/9/2012	Cancervax Corp	4	Statement of changes in beneficial ownership of securities	$8.45M
	3/6/2012	Cancervax Corp	4	Statement of changes in beneficial ownership of securities	$178.9K
	3/3/2011	Cancervax Corp	4	Statement of changes in beneficial ownership of securities
	4/5/2010	Cancervax Corp	4	Statement of changes in beneficial ownership of securities
	3/9/2010		5	Annual statement of changes in beneficial ownership of securitie...
	2/2/2010	Cancervax Corp	4	Statement of changes in beneficial ownership of securities
	4/3/2009	Cancervax Corp	4	Statement of changes in beneficial ownership of securities
	3/24/2009	Cancervax Corp	4	Statement of changes in beneficial ownership of securities
	4/3/2008	Cancervax Corp	4	Statement of changes in beneficial ownership of securities
	6/15/2007	Cancervax Corp	4	Statement of changes in beneficial ownership of securities
	5/9/2006	Cancervax Corp	4	Statement of changes in beneficial ownership of securities
	5/9/2006	Cancervax Corp	3	Initial statement of beneficial ownership of securities

Incoming Payments

This individual has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This individual has not disclosed any outgoing payments to lobbying groups.

Affiliated Entities

• Cancervax Corp
• Cullinan Oncology, LLC
• Harpoon Therapeutics, Inc.
• Tcr2 Therapeutics, Inc.